The Baclofen market refers to the global industry involved in the development, production, and distribution of Baclofen, a medication used to treat muscle symptoms caused by multiple sclerosis or spinal cord injury. As a key player in the pharmaceutical industry, the Baclofen market size is estimated to be around $1.4 billion in 2025. The growth outlook for the Baclofen market forecast is positive, driven by increasing demand for effective treatments for multiple sclerosis and spinal cord injuries, with a market forecast expected to reach $2.5 billion by 2033. The industry expansion is expected to be driven by factors such as advancements in muscle relaxant therapies, central nervous system treatments, and neurological disorder medications, with a compound annual growth rate (CAGR) of around 7.5% during the forecast period. Key forces shaping the industry include technology shifts in pharmaceutical manufacturing, regulations regarding drug safety and efficacy, and consumer behavior towards healthcare and wellness.